Newsletter | October 14, 2026

10.14.26 -- Servant Leadership, AI Validation, CAR-T Advances, And Trial Success

FEATURED ARTICLE

The Strength Behind Servant Leadership

Servant leadership means putting people first because results follow people, not the other way around, writes Boehringer Ingelheim’s Christine Sakdalan.

INDUSTRY INSIGHTS

"Miracle Road" Brings Human Focus To RTP's Miraculous Existence

Discover how university, business, and government partnerships transformed thousands of acres of North Carolina woodland into a global center for research, technology, and life sciences.

Mobile Ophthalmic Assessment Options For Decentralized Clinical Trials

Eye exams need calibrated equipment and trained staff. These three mobile delivery models bring that capability directly to your trial participants.

Understanding When AI Models Need To Be Validated For Regulated Industries

Focus AI validation on decision impact rather than just algorithms. Aligning assurance with intended use and human oversight ensures safety while enabling faster, more compliant adoption.

Turning Patient Advocacy Into Meaningful Trial Engagement

See how structured PAO engagement can inform protocol design, reduce participation barriers, and strengthen recruitment and retention.

Analytical Strategies For Impurity Control In Antibody-Drug Conjugates

Antibody-drug conjugates (ADCs) combine antibody targeting with potent cytotoxic payloads to treat resistant cancers, but their complexity requires phase-appropriate analytical strategies.

Eliminating Barriers To In Vivo And Ex Vivo CAR-T Delivery

Learn how lentiviral vector processes evolve for in vivo and ex vivo CAR‑T—covering yield, purity, scalability, and shifting regulatory demands for safe, consistent systemic delivery.

Overcome Common Pre-Filled Syringe Challenges Through Partnership

Pre-filled syringes are among pharma’s fastest-growing sectors, improving patient safety and reducing costs. Yet filling them presents unique manufacturing challenges that require specialized expertise.

Connect With Life Science Leader: